Track topics on Twitter Track topics that are important to you
(Burness) PATH's Malaria Vaccine Initiative and the US Department of Defense's Walter Reed Army Institute of Research announced today that vaccinations are under way in a clinical trial to evaluate modifications to the vaccine regimen of GSK's RTS,S/AS01 (RTS,S) malaria vaccine candidate. The partners seek to understand if these modifications will provide equal or increased protection compared to the standard pediatric regimen.
Original Article: PATH and WRAIR announce largest-ever controlled malaria infectionNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...